Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA RNA-based Biopharmaceuticals market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA RNA-based Biopharmaceuticals market. Detailed analysis of key players, along with key growth strategies adopted by RNA-based Biopharmaceuticals industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Gradalis
Calimmune Inc
RXi
Silenseed
Benitec Biopharma
Abbott Laboratories
Senesco
Silence Therapeutics
Roche
Quark
Sanofi-Aventis
Dicerna
Tekmira
Pfizer
Arrowhead Pharmaceuticals
Alnylam Pharmaceuticals
By Type:
Therapeutics
Vaccines
By End-User:
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of RNA-based Biopharmaceuticals Market
-
1.3 Market Segment by Type
-
1.3.1 USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Therapeutics from 2016 to 2027
-
1.3.2 USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Vaccines from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Cancer from 2016 to 2027
-
1.4.2 USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Diabetes from 2016 to 2027
-
1.4.3 USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Tuberculosis from 2016 to 2027
-
1.4.4 USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
1.4.5 USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of RNA-based Biopharmaceuticals Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of RNA-based Biopharmaceuticals by Major Types
-
3.4.1 Market Size and Growth Rate of Therapeutics
-
3.4.2 Market Size and Growth Rate of Vaccines
4 Segmentation of RNA-based Biopharmaceuticals Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of RNA-based Biopharmaceuticals by Major End-Users
-
4.4.1 Market Size and Growth Rate of RNA-based Biopharmaceuticals in Cancer
-
4.4.2 Market Size and Growth Rate of RNA-based Biopharmaceuticals in Diabetes
-
4.4.3 Market Size and Growth Rate of RNA-based Biopharmaceuticals in Tuberculosis
-
4.4.4 Market Size and Growth Rate of RNA-based Biopharmaceuticals in Cardiovascular Diseases
-
4.4.5 Market Size and Growth Rate of RNA-based Biopharmaceuticals in Others
5 Market Analysis by Regions
-
5.1 USA RNA-based Biopharmaceuticals Production Analysis by Regions
-
5.2 USA RNA-based Biopharmaceuticals Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA RNA-based Biopharmaceuticals Landscape Analysis
-
6.1 West USA RNA-based Biopharmaceuticals Landscape Analysis by Major Types
-
6.2 West USA RNA-based Biopharmaceuticals Landscape Analysis by Major End-Users
7 South USA RNA-based Biopharmaceuticals Landscape Analysis
-
7.1 South USA RNA-based Biopharmaceuticals Landscape Analysis by Major Types
-
7.2 South USA RNA-based Biopharmaceuticals Landscape Analysis by Major End-Users
8 Middle West USA RNA-based Biopharmaceuticals Landscape Analysis
-
8.1 Middle West USA RNA-based Biopharmaceuticals Landscape Analysis by Major Types
-
8.2 Middle West USA RNA-based Biopharmaceuticals Landscape Analysis by Major End-Users
9 Northeast USA RNA-based Biopharmaceuticals Landscape Analysis
-
9.1 Northeast USA RNA-based Biopharmaceuticals Landscape Analysis by Major Types
-
9.2 Northeast USA RNA-based Biopharmaceuticals Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Gradalis
-
10.1.1 Gradalis Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Calimmune Inc
-
10.2.1 Calimmune Inc Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 RXi
-
10.3.1 RXi Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Silenseed
-
10.4.1 Silenseed Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Benitec Biopharma
-
10.5.1 Benitec Biopharma Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Abbott Laboratories
-
10.6.1 Abbott Laboratories Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Senesco
-
10.7.1 Senesco Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Silence Therapeutics
-
10.8.1 Silence Therapeutics Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Roche
-
10.9.1 Roche Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Quark
-
10.10.1 Quark Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Sanofi-Aventis
-
10.11.1 Sanofi-Aventis Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Dicerna
-
10.12.1 Dicerna Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Tekmira
-
10.13.1 Tekmira Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
-
10.14 Pfizer
-
10.14.1 Pfizer Company Profile and Recent Development
-
10.14.2 Market Performance
-
10.14.3 Product and Service Introduction
-
10.15 Arrowhead Pharmaceuticals
-
10.15.1 Arrowhead Pharmaceuticals Company Profile and Recent Development
-
10.15.2 Market Performance
-
10.15.3 Product and Service Introduction
-
10.16 Alnylam Pharmaceuticals
-
10.16.1 Alnylam Pharmaceuticals Company Profile and Recent Development
-
10.16.2 Market Performance
-
10.16.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Therapeutics from 2016 to 2027
-
Figure USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Vaccines from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Cancer from 2016 to 2027
-
Figure USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Diabetes from 2016 to 2027
-
Figure USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Tuberculosis from 2016 to 2027
-
Figure USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
Figure USA RNA-based Biopharmaceuticals Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA RNA-based Biopharmaceuticals Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of RNA-based Biopharmaceuticals Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of RNA-based Biopharmaceuticals
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of RNA-based Biopharmaceuticals by Different Types from 2016 to 2027
-
Table Consumption Share of RNA-based Biopharmaceuticals by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Therapeutics
-
Figure Market Size and Growth Rate of Vaccines
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of RNA-based Biopharmaceuticals by Different End-Users from 2016 to 2027
-
Table Consumption Share of RNA-based Biopharmaceuticals by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Cancer
-
Figure Market Size and Growth Rate of Diabetes
-
Figure Market Size and Growth Rate of Tuberculosis
-
Figure Market Size and Growth Rate of Cardiovascular Diseases
-
Figure Market Size and Growth Rate of Others
-
Table USA RNA-based Biopharmaceuticals Production by Regions
-
Table USA RNA-based Biopharmaceuticals Production Share by Regions
-
Figure USA RNA-based Biopharmaceuticals Production Share by Regions in 2016
-
Figure USA RNA-based Biopharmaceuticals Production Share by Regions in 2021
-
Figure USA RNA-based Biopharmaceuticals Production Share by Regions in 2027
-
Table USA RNA-based Biopharmaceuticals Consumption by Regions
-
Table USA RNA-based Biopharmaceuticals Consumption Share by Regions
-
Figure USA RNA-based Biopharmaceuticals Consumption Share by Regions in 2016
-
Figure USA RNA-based Biopharmaceuticals Consumption Share by Regions in 2021
-
Figure USA RNA-based Biopharmaceuticals Consumption Share by Regions in 2027
-
Table West USA RNA-based Biopharmaceuticals Consumption by Types from 2016 to 2027
-
Table West USA RNA-based Biopharmaceuticals Consumption Share by Types from 2016 to 2027
-
Figure West USA RNA-based Biopharmaceuticals Consumption Share by Types in 2016
-
Figure West USA RNA-based Biopharmaceuticals Consumption Share by Types in 2021
-
Figure West USA RNA-based Biopharmaceuticals Consumption Share by Types in 2027
-
Table West USA RNA-based Biopharmaceuticals Consumption by End-Users from 2016 to 2027
-
Table West USA RNA-based Biopharmaceuticals Consumption Share by End-Users from 2016 to 2027
-
Figure West USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2016
-
Figure West USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2021
-
Figure West USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2027
-
Table South USA RNA-based Biopharmaceuticals Consumption by Types from 2016 to 2027
-
Table South USA RNA-based Biopharmaceuticals Consumption Share by Types from 2016 to 2027
-
Figure South USA RNA-based Biopharmaceuticals Consumption Share by Types in 2016
-
Figure South USA RNA-based Biopharmaceuticals Consumption Share by Types in 2021
-
Figure South USA RNA-based Biopharmaceuticals Consumption Share by Types in 2027
-
Table South USA RNA-based Biopharmaceuticals Consumption by End-Users from 2016 to 2027
-
Table South USA RNA-based Biopharmaceuticals Consumption Share by End-Users from 2016 to 2027
-
Figure South USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2016
-
Figure South USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2021
-
Figure South USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2027
-
Table Middle West USA RNA-based Biopharmaceuticals Consumption by Types from 2016 to 2027
-
Table Middle West USA RNA-based Biopharmaceuticals Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA RNA-based Biopharmaceuticals Consumption Share by Types in 2016
-
Figure Middle West USA RNA-based Biopharmaceuticals Consumption Share by Types in 2021
-
Figure Middle West USA RNA-based Biopharmaceuticals Consumption Share by Types in 2027
-
Table Middle West USA RNA-based Biopharmaceuticals Consumption by End-Users from 2016 to 2027
-
Table Middle West USA RNA-based Biopharmaceuticals Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2016
-
Figure Middle West USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2021
-
Figure Middle West USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2027
-
Table Northeast USA RNA-based Biopharmaceuticals Consumption by Types from 2016 to 2027
-
Table Northeast USA RNA-based Biopharmaceuticals Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA RNA-based Biopharmaceuticals Consumption Share by Types in 2016
-
Figure Northeast USA RNA-based Biopharmaceuticals Consumption Share by Types in 2021
-
Figure Northeast USA RNA-based Biopharmaceuticals Consumption Share by Types in 2027
-
Table Northeast USA RNA-based Biopharmaceuticals Consumption by End-Users from 2016 to 2027
-
Table Northeast USA RNA-based Biopharmaceuticals Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2016
-
Figure Northeast USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2021
-
Figure Northeast USA RNA-based Biopharmaceuticals Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Gradalis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gradalis
-
Figure Sales and Growth Rate Analysis of Gradalis
-
Figure Revenue and Market Share Analysis of Gradalis
-
Table Product and Service Introduction of Gradalis
-
Table Company Profile and Development Status of Calimmune Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calimmune Inc
-
Figure Sales and Growth Rate Analysis of Calimmune Inc
-
Figure Revenue and Market Share Analysis of Calimmune Inc
-
Table Product and Service Introduction of Calimmune Inc
-
Table Company Profile and Development Status of RXi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RXi
-
Figure Sales and Growth Rate Analysis of RXi
-
Figure Revenue and Market Share Analysis of RXi
-
Table Product and Service Introduction of RXi
-
Table Company Profile and Development Status of Silenseed
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silenseed
-
Figure Sales and Growth Rate Analysis of Silenseed
-
Figure Revenue and Market Share Analysis of Silenseed
-
Table Product and Service Introduction of Silenseed
-
Table Company Profile and Development Status of Benitec Biopharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Benitec Biopharma
-
Figure Sales and Growth Rate Analysis of Benitec Biopharma
-
Figure Revenue and Market Share Analysis of Benitec Biopharma
-
Table Product and Service Introduction of Benitec Biopharma
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of Senesco
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Senesco
-
Figure Sales and Growth Rate Analysis of Senesco
-
Figure Revenue and Market Share Analysis of Senesco
-
Table Product and Service Introduction of Senesco
-
Table Company Profile and Development Status of Silence Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Silence Therapeutics
-
Figure Sales and Growth Rate Analysis of Silence Therapeutics
-
Figure Revenue and Market Share Analysis of Silence Therapeutics
-
Table Product and Service Introduction of Silence Therapeutics
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Quark
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quark
-
Figure Sales and Growth Rate Analysis of Quark
-
Figure Revenue and Market Share Analysis of Quark
-
Table Product and Service Introduction of Quark
-
Table Company Profile and Development Status of Sanofi-Aventis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi-Aventis
-
Figure Sales and Growth Rate Analysis of Sanofi-Aventis
-
Figure Revenue and Market Share Analysis of Sanofi-Aventis
-
Table Product and Service Introduction of Sanofi-Aventis
-
Table Company Profile and Development Status of Dicerna
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dicerna
-
Figure Sales and Growth Rate Analysis of Dicerna
-
Figure Revenue and Market Share Analysis of Dicerna
-
Table Product and Service Introduction of Dicerna
-
Table Company Profile and Development Status of Tekmira
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tekmira
-
Figure Sales and Growth Rate Analysis of Tekmira
-
Figure Revenue and Market Share Analysis of Tekmira
-
Table Product and Service Introduction of Tekmira
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Arrowhead Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arrowhead Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Arrowhead Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Arrowhead Pharmaceuticals
-
Table Product and Service Introduction of Arrowhead Pharmaceuticals
-
Table Company Profile and Development Status of Alnylam Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alnylam Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Alnylam Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals
-
Table Product and Service Introduction of Alnylam Pharmaceuticals
-
